Quantum-Si (QSI) Set to Announce Quarterly Earnings on Thursday

Quantum-Si (NASDAQ:QSI) is expected to release its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Quantum-Si to post earnings of ($0.13) per share and revenue of $0.27 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

Quantum-Si (NASDAQ:QSI) last announced its earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. The company had revenue of $0.34 million during the quarter, compared to analyst estimates of $0.30 million. On average, analysts expect Quantum-Si to post ($0.47) EPS for the current fiscal year and ($0.42) EPS for the next fiscal year.

Quantum-Si Trading Up 3.2%

QSI opened at $1.30 on Wednesday. Quantum-Si has a 1-year low of $0.69 and a 1-year high of $1.95. The company has a market capitalization of $284.54 million, a PE ratio of -2.83 and a beta of 3.26. The firm’s 50 day simple moving average is $1.06 and its two-hundred day simple moving average is $0.97.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on QSI shares. HC Wainwright set a $4.00 price objective on shares of Quantum-Si in a research report on Friday, October 9th. Weiss Ratings raised Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, September 24th. Wall Street Zen raised Quantum-Si from a “sell” rating to a “hold” rating in a report on Tuesday, October 27th. Finally, Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a research report on Friday, August 14th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Quantum-Si has an average rating of “Hold” and a consensus target price of $2.50.

Quantum-Si Company Profile

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on transforming protein analysis through next-generation proteomics. The company develops tools designed to identify and characterize proteins at the single-molecule level, with potential applications in drug discovery, translational research, diagnostics development and precision medicine.

Its primary offering is the Platinum platform, which combines a benchtop sequencing instrument, semiconductor-based technology, consumables and data-analysis software.